Know Cancer

or
forgot password

Quantification of Therapy Effects After Microsurgery, Percutaneous Irradiation and Chemotherapy by FET-PET Analysis


N/A
18 Years
N/A
Not Enrolling
Both
Glioblastoma Multiforme

Thank you

Trial Information

Quantification of Therapy Effects After Microsurgery, Percutaneous Irradiation and Chemotherapy by FET-PET Analysis


Inclusion Criteria:



- neuroradiologically suspected Glioblastoma multiforme

- histological verification will be obtained either by microsurgery or by stereotactic
biopsy. The neuropathological diagnosis will be verified by a reference
neuropathologist

- patients will undergo radiochemotherapy subsequent to surgical procedure

- patients older than 18 years

- Karnofsky Performance Score >=70

- pregnant or nursing female patients will not be included in this study

- safe contraceptive methods during the radiochemotherapy and chemotherapy

Exclusion Criteria:

- patients in whom informed consent cannot be obtained due to organic brain syndrome or
insufficient language skills

- patients who cannot lie quiet for a time period of app. two hours during the FET-PEt
scan

- medical history of a metastatic brain disease

- patients in whom an MRI scan cannot be performed due to claustrophobia metallic
protheses or pacemakers etc.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Overall Survival

Outcome Time Frame:

46 months

Safety Issue:

No

Principal Investigator

Joerg C. Tonn, Prof. Dr.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Department of Neurosurgery, LMU, Munich

Authority:

Germany: Federal Office for Radiation Protection

Study ID:

GGN-ZP9

NCT ID:

NCT01089868

Start Date:

January 2007

Completion Date:

July 2012

Related Keywords:

  • Glioblastoma Multiforme
  • Glioblastoma multiforme
  • Microsurgery
  • Stereotactic biopsy
  • Radiochemotherapy
  • Temodar
  • FET PET
  • Molecular imaging
  • Glioblastoma

Name

Location